1352619-72-7

Basic information

• Product Name: 2-(4-fluorophenyl)-N-[4-(2-{[4-(morpholin-4-ylcarbonyl)-2-(trifluoromethoxy)phenyl]amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]acetamide
• Synonyms: 2-(4-fluorophenyl)-N-[4-(2-{[4-(morpholin-4-ylcarbonyl)-2-(trifluoromethoxy)phenyl]amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]acetamide
• CAS NO: 1352619-72-7
• Molecular Weight: 634.59
• Mol File: 1352619-72-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(4-fluorophenyl)-N-[4-(2-{[4-(morpholin-4-ylcarbonyl)-2-(trifluoromethoxy)phenyl]amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-fluorophenyl)-N-[4-(2-{[4-(morpholin-4-ylcarbonyl)-2-(trifluoromethoxy)phenyl]amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]acetamide(1352619-72-7)
• EPA Substance Registry System: 2-(4-fluorophenyl)-N-[4-(2-{[4-(morpholin-4-ylcarbonyl)-2-(trifluoromethoxy)phenyl]amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]acetamide(1352619-72-7)

Safety Data

• Hazardous Substances Data: 1352619-72-7(Hazardous Substances Data)

Upstream product

• 1352621-29-4 ethyl 4-bromo-3-(trifluoromethoxy)benzoate 
• 1260742-02-6 ethyl 4-amino-3-(trifluoromethoxy)benzoate 
• 1352621-30-7 [4-bromo-3-(trifluoromethoxy)phenyl](morpholin-4-yl)methanone 
• 1352620-72-4 N-[4-(2-amino[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]-2-(4-fluorophenyl)-acetamide 
• 1008769-87-6 4-bromo-3-(trifluoromethoxy)benzoic acid 
• 175278-22-5 4-amino-3-(trifluoromethoxy)benzoic acid 

Relevant articles and documents

SUBSTITUTED TRIAZOLOPYRIDINES

The present invention relates to substituted triazolopyridine compounds of general formula (I) : in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease such as tumours and proliferative diseases, as well as to intermediate compounds useful in the preparation of said compounds.